Profound Medical and Philips Ink Sales, Marketing Agreement
Profound Medical has inked a sales and marketing agreement with Royal Philips to launch Profound’s Tulsa-Pro minimally invasive ablation system for treatment of prostate cancer.
Both companies will market the device in Europe, Canada, the U.S. and other markets. The agreement is subject to customary conditions. — Anisa Jibrell